Max Hospital, Patparganj, New Delhi
Elevate Health Solutions, Rajouri Garden, New Delhi
Max Hospital, Vaishali, Ghaziabad
Max Hospital, Patparganj, New Delhi
Elevate Health Solutions, Rajouri Garden, New Delhi
Max Hospital, Vaishali, Ghaziabad
23 Sep, 2026
Being diagnosed with esophageal cancer (food pipe cancer) can leave patients and families with many questions.
Is chemotherapy enough? Is radiotherapy necessary? When is surgery required? Can esophageal cancer be treated without surgery? Is robotic or laparoscopic surgery better? And what happens after the operation?
There is no single treatment that is best for every patient with food pipe cancer. The right treatment depends on factors such as the stage and location of the cancer, the type of cancer, its response to chemotherapy or chemoradiotherapy, the patient's overall health, and whether surgery can be performed safely.
For many patients with potentially operable esophageal cancer treatment involves a carefully planned combination of chemotherapy and/or chemoradiotherapy followed by surgery.
Treatment for oesophageal cancer is usually planned by a multidisciplinary team after evaluating the extent of disease.
Depending on the individual case, treatment may include:
The important point is that treatment should be individualized rather than decided on the basis of one scan, one symptom, or one treatment modality alone.
For certain locally advanced oesophageal cancers, chemotherapy or chemoradiotherapy may be given before surgery.
This approach is intended to treat cancer cells beyond the visible tumour and may help reduce the extent of disease before an operation. This helps improve survival after surgery.
After completing the planned treatment, the response is assessed.
PET-CT is usually performed around 4–6 weeks after treatment, followed by further evaluation when appropriate, including endoscopy.
This reassessment is important because the next step depends on how the cancer has responded.
This is one of the most common questions patients ask.
If there is no obvious disease on imaging and endoscopy, surgery may sometimes be avoided in carefully selected patients, but this is not automatically the safest option for everyone.
Some patients with squamous cell carcinoma can have a complete response to chemoradiotherapy. However, this requires very close surveillance with appropriate investigations, because cancer can return later even when there is initially no detectable disease.
Therefore, the decision to proceed with or avoid surgery should be made after detailed assessment by the treating team.
For many patients with operable oesophageal cancer, surgery remains an important part of potentially curative treatment, particularly when residual disease is present after chemotherapy or chemoradiotherapy.
The decision is based on factors including:
Current treatment approaches generally favour offering surgery to appropriate surgical candidates rather than simply assuming that a good response to chemotherapy or radiotherapy means surgery is no longer required.
A scan may show that the tumour has reduced significantly, but imaging alone may not always tell us whether microscopic cancer cells remain.
It is obvious that patients in whom there is incomplete response would be recommended surgery. In selected patients, endoscopy and other investigations can provide additional information. If residual disease is suspected or identified, surgery ensures that the affected oesophagus and nearby lymph nodes are removed thereby ensuring complete clearance of disease. Even if there is a seemingly complete disappearance of oesophagus, most patients especially if cancer is adenocarcinoma (a subtype of oesophageal cancer) or affects the mid thirds of oesophagus should be offered surgery because of very low complete response rates in former and difficulty in treating disease when it recurs at this location in latter
This is why treatment planning after chemoradiotherapy is just as important as the initial treatment decision.
The surgery to remove part or most of the diseased esophagus is called an esophagectomy.
The exact procedure varies according to the location of the tumour and the patient's individual anatomy.
In many cases, the operation involves working through the chest and abdomen, and in selected patients a small incision in the neck may also be required.
Procedure is broadly done in three stages:
The cancerous portion of the esophagus is carefully separated from surrounding tissues.
The nearby lymph nodes are also removed because these nodes often harbour disease (and removing them improves outcomes) and the fact that examining these lymph nodes helps determine the extent of cancer and provides important information for further treatment planning
The stomach is mobilized through the abdomen, commonly using a laparoscopic or robotic approach in suitable patients.
The stomach is then prepared to take over the role of the removed section of the food pipe.
The prepared stomach is brought upward through the chest and connected to the remaining esophagus.
Depending on the location of the tumour and the surgical technique used, a neck incision may or may not be required.
The procedure can take approximately 5–8 hours, depending on the complexity of the surgery and the individual patient.
Traditionally, esophageal cancer surgery could require large open incisions.
Today, minimally invasive techniques such as laparoscopic and robotic surgery can be used for suitable patients.
The potential advantages include:
However, robotic or laparoscopic surgery is not automatically the right choice for every patient.
The surgical approach should depend on the tumour, anatomy, previous treatments, patient's fitness, and the surgeon's assessment.
The objective is not simply to use the newest technology. The objective is to perform safe and appropriate cancer surgery while achieving sound oncological outcomes.
Esophagectomy is a major operation, so recovery is planned carefully.
Patients may initially spend time in the ICU before being shifted to the ward as their condition stabilizes.
In many cases, hospital recovery may take approximately 7–10 days, although the duration varies depending on the patient's condition, the type of surgery, and recovery.
After surgery, patients are generally encouraged to start moving as early as safely possible.
Chest physiotherapy and breathing exercises can also be important parts of recovery.
Early mobilization helps patients gradually regain strength and supports recovery.
Another most asked common question is this.
The answer is: in selected situations, possibly - but it should never be assumed simply because a scan looks clear.
Some patients, particularly those with certain squamous cell cancers, can have a complete response to chemoradiotherapy.
In carefully selected patients, a surveillance or “watch-and-wait” approach may be considered by the treating team.
However, this requires intensive follow-up.
Follow-up may involve:
If evidence of recurrent or residual disease appears, surgery may need to be reconsidered.
Therefore, avoiding surgery is not the same as finishing treatment. It means entering a structured surveillance programme where recurrence needs to be detected as early as possible.
There is no universal “best treatment” for every patient.
For an individual patient, the best treatment is the one that is appropriate for the cancer stage and type, technically feasible, medically safe, and planned after a complete evaluation.
For many patients with localized or locally advanced, operable disease, treatment may involve:
Chemotherapy/chemoradiotherapy → response assessment → surgery when appropriate → recovery and structured follow-up
In other patients, the treatment pathway may be different.
This is why an esophageal cancer diagnosis should ideally be discussed with a team experienced in managing complex gastrointestinal and esophageal cancers.
A second opinion can be particularly useful when you are unsure about:
A second opinion does not necessarily mean changing doctors or treatment.
Sometimes, it simply helps patients and families understand their options and make a more informed decision.
Because esophagectomy is a complex cancer operation, experience and multidisciplinary planning matter.
When consulting an esophageal cancer surgeon, one should consider asking:
These questions can help you understand not only the operation, but the complete treatment journey.
Treating esophageal cancer is not simply about removing a tumour.
It involves making the right decision at the right stage—from initial staging and preoperative treatment to surgery, nutrition, recovery and long-term follow-up.
For suitable patients, minimally invasive or robotic approaches may support recovery, while careful nutritional management and follow-up remain essential parts of the journey.
If you or a family member has been diagnosed with esophageal cancer, understanding the treatment plan can make the process less overwhelming.
If you have been advised chemotherapy, chemoradiotherapy or surgery for esophageal/food pipe cancer, a detailed consultation can help you understand your diagnosis, treatment options and whether surgery may be appropriate in your case.
Dr. Vivek Mangla is a gastrointestinal and hepatopancreatobiliary cancer surgeon associated with Max Super Speciality Hospital, Patparganj and Max Super Speciality Hospital, Vaishali.
For consultation or a second opinion, patients can discuss their reports, scans and previous treatment with the surgical team to understand the next appropriate step.
Do not delay evaluation if you have already been diagnosed with esophageal cancer. An informed treatment decision starts with understanding the disease and its treatment options.
Room No. 2623, 6th Floor, Tower 2
Mon to Sat: 02:00 pm-05:00 pm
Room No. 2014, Ground Floor, West Wing
Mon to Sat : 8:30am - 9:00am, 6:00pm-7:00pm
E29B, Ground Floor, E Block, Rajouri Garden, New Delhi-i 110027
Mon to Sat : 7:30-8:30 am, 7:30 -8:30 pm
